The PBS restriction level for fixed dose combination inhaled corticosteroid (ICS)/long acting beta-antagonist (LABA) inhalers for childhood asthma is to be increased to Authority Required (Streamlined), the Pharmaceutical Benefits Advisory Committee (PBAC) has signalled . The move is a reiteration of the PBAC’s 2017 recommendations aimed at curbing inappropriate first line use of fixed dose combination ...
PBS tightens up on FDC inhaler use in child asthma
By Mardi Chapman
14 Jun 2018